References:

Anhê, F. F., Zlitni, S., Zhang, S.-Y., Choi, B. S.-Y., Chen, C. Y., Foley, K. P., Barra, N. G., Surette, M. G., Biertho, L., Richard, D., Tchernof, A., Lam, T. K. T., Marette, A., & Schertzer, J. (2023). Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity. Gut, 72(3), 460–472

‌Lomax AR, Calder PC. Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr Pharm Des. 2009;15(13):1428-518. doi: 10.2174/138161209788168155. PMID: 19442167.

Forslund, K., Hildebrand, F., Nielsen, T. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015). https://doi.org/10.1038/nature15766

Qin, J., Li, Y., Cai, Z. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012). https://doi.org/10.1038/nature11450

Zhao, L., et al. (2018). Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science, 359(6380), 1151-1156.

Tilg, H., & Kaser, A. (2011). Gut microbiome, obesity, and metabolic dysfunction. Journal of Clinical Investigation, 121(6), 2126-2132.